Evidence map›Paper›PMID 29631342›Full record

ArticleHepatology (Baltimore, Md.)2018

Disruption of Renal Arginine Metabolism Promotes Kidney Injury in Hepatorenal Syndrome in Mice.

Zoltan V Varga, Katalin Erdelyi, Janos Paloczi, Resat Cinar, Zsuzsanna K Zsengeller, Tony Jourdan, Csaba Matyas, Balazs Tamas Nemeth, Adrien Guillot, Xiaogang Xiang and 7 more

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. The Role of Nitric Oxide in Chronic Liver Disease: A Review.Journal of clinical and translational hepatology · 2026
    Review
  3. Article
  4. The Link between Alcohol Consumption and Kidney Injury.The American journal of pathology · 2026
    Review
  5. Article
  6. Article
  7. Immunomodulatory Functions of Intercalated Cells in Kidney Autoimmunity.bioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Hepatorenal Syndrome-Novel Insights into Diagnostics and Treatment.International journal of molecular sciences · 2023
    Review
  14. Article
  15. Impact of renal tubularFrontiers in molecular biosciences · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Zoltan V VargaLaboratory of Cardiovascular Physiology and Tissue Injury, National Institutes of Health/NIAAA, Bethesda, MD.ORCID 0000-0002-2758-0784
Katalin ErdelyiLaboratory of Cardiovascular Physiology and Tissue Injury, National Institutes of Health/NIAAA, Bethesda, MD.
Janos PalocziLaboratory of Cardiovascular Physiology and Tissue Injury, National Institutes of Health/NIAAA, Bethesda, MD.
Resat CinarLaboratory of Physiologic Studies, National Institutes of Health/NIAAA, Bethesda, MD.ORCID 0000-0002-8597-7253
Zsuzsanna K ZsengellerDepartment of Medicine, Division of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA.
Tony JourdanLaboratory of Physiologic Studies, National Institutes of Health/NIAAA, Bethesda, MD.ORCID 0000-0001-7955-8127
Csaba MatyasLaboratory of Cardiovascular Physiology and Tissue Injury, National Institutes of Health/NIAAA, Bethesda, MD.
Balazs Tamas NemethLaboratory of Cardiovascular Physiology and Tissue Injury, National Institutes of Health/NIAAA, Bethesda, MD.
Adrien GuillotLaboratory of Liver Diseases, National Institutes of Health/NIAAA, Bethesda, MD.
Xiaogang XiangLaboratory of Liver Diseases, National Institutes of Health/NIAAA, Bethesda, MD.
Adam MehalLaboratory of Cardiovascular Physiology and Tissue Injury, National Institutes of Health/NIAAA, Bethesda, MD.
György HaskóDepartment of Anesthesiology, Columbia University, New York, NY.
Isaac E StillmanDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, MA.
Seymour RosenDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, MA.
Bin GaoLaboratory of Liver Diseases, National Institutes of Health/NIAAA, Bethesda, MD.
George KunosLaboratory of Physiologic Studies, National Institutes of Health/NIAAA, Bethesda, MD.
Pal PacherLaboratory of Cardiovascular Physiology and Tissue Injury, National Institutes of Health/NIAAA, Bethesda, MD.ORCID 0000-0001-7036-8108
National Institutes of Health · USBeth Israel Deaconess Medical Center · USColumbia University · US

Funding

Endocannabinoids And Energy HomeostasisZIAAA000350 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI KUNOS, GEORGE · 2009 to 2025
$28.4M
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injuryZIAAA000375 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI PACHER, PAL · 2009 to 2025
$27.8M
Endocannabinoids And The Control Of Cardiovascular FunctionZIAAA000351 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI KUNOS, GEORGE · 2009 to 2025
$11.8M
Intramural NIH HHS ZIA AA000375Intramural Research Program of NIAAA/NIH 1ZIAAA000375-11
6 · The paper itself

Abstract

Tubular dysfunction is an important feature of renal injury in hepatorenal syndrome (HRS) in patients with end-stage liver disease. The pathogenesis of kidney injury in HRS is elusive, and there are no clinically relevant rodent models of HRS. We investigated the renal consequences of bile duct ligation (BDL)-induced hepatic and renal injury in mice in vivo by using biochemical assays, real-time polymerase chain reaction (PCR), Western blot, mass spectrometry, histology, and electron microscopy. BDL resulted in time-dependent hepatic injury and hyperammonemia which were paralleled by tubular dilation and tubulointerstitial nephritis with marked upregulation of lipocalin-2, kidney injury molecule 1 (KIM-1) and osteopontin. Renal injury was associated with dramatically impaired microvascular flow and decreased endothelial nitric oxide synthase (eNOS) activity. Gene expression analyses signified proximal tubular epithelial injury, tissue hypoxia, inflammation, and activation of the fibrotic gene program. Marked changes in renal arginine metabolism (upregulation of arginase-2 and downregulation of argininosuccinate synthase 1), resulted in decreased circulating arginine levels. Arginase-2 knockout mice were partially protected from BDL-induced renal injury and had less impairment in microvascular function. In human-cultured proximal tubular epithelial cells hyperammonemia per se induced upregulation of arginase-2 and markers of tubular cell injury.

conclusionWe propose that hyperammonemia may contribute to impaired renal arginine metabolism, leading to decreased eNOS activity, impaired microcirculation, tubular cell death, tubulointerstitial nephritis and fibrosis. Genetic deletion of arginase-2 partially restores microcirculation and thereby alleviates tubular injury. We also demonstrate that BDL in mice is an excellent, clinically relevant model to study the renal consequences of HRS. (Hepatology 2018; 00:000-000).

Indexed as

Acute Kidney InjuryAnimalsArginineBiomarkersBiopsy, NeedleDisease Models, AnimalDisease ProgressionHepatorenal SyndromeHumansImmunohistochemistryKidney TubulesMaleMiceMice, Inbred C57BLMice, KnockoutNitric Oxide SynthaseArginineBiomarkersNitric Oxide Synthase

Identifiers

PMID29631342
PMCPMC6173643
OpenAlexW2798055176

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.